Why is 214 nm used for peptide detection?

The peptide bond itself absorbs strongly near 214 nm, so detection at that wavelength responds to the backbone rather than depending on aromatic side chains.

Can HPLC alone confirm that a vial contains the intended peptide?

No. Chromatography reports how the sample separates, not what the separated component is. Identity assignment requires a mass measurement or another orthogonal method.

What does an unexpected extra peak indicate?

It indicates a detected component other than the main peak. Interpretation requires the method context; possibilities include synthesis-related impurities, degradation products, or solvent and matrix peaks.

Is a single injection sufficient?

Analytical practice generally relies on replicate injections and system suitability checks so that reported values reflect a stable, reproducible measurement.

Laboratory Method Guide

HPLC and Mass Spectrometry in Peptide Identity and Purity Testing

How chromatographic separation and mass analysis answer two different analytical questions about a lyophilized peptide lot.

Two questions, two methods

Peptide characterization usually separates into two questions. Purity asks how much of the detected material is the main component. Identity asks whether that main component is the intended molecule.

High performance liquid chromatography addresses the first question. Mass spectrometry addresses the second. Neither method substitutes for the other, which is why analytical packages commonly report both.

Reversed-phase HPLC

In reversed-phase HPLC a sample is carried through a hydrophobic stationary phase by a gradient of aqueous and organic solvent. Components partition differently between phases and therefore elute at different retention times.

A detector, typically ultraviolet absorbance near 214 nm for peptide bonds, records the eluting components as peaks. Purity is reported as the percentage of total integrated peak area attributable to the main peak under the stated gradient and detection conditions.

Mass spectrometry

Mass spectrometry ionizes the sample and measures mass-to-charge ratios. For peptides, electrospray ionization commonly produces multiply charged ions from which the neutral molecular mass is calculated.

The observed mass is compared with the theoretical mass derived from the intended sequence or formula. Agreement within the method tolerance supports the identity assignment; a mass offset can indicate an incorrect sequence, an unintended modification, or residual counter-ions.

What each result supports

HPLC area percent supports a statement about relative composition under one method.
Mass agreement supports a statement about molecular identity.
Retention-time reproducibility supports method consistency between injections.
Neither method supports a sterility, endotoxin, potency, or safety conclusion.

Common sources of variation

Gradient slope and column temperature shift retention times.
Detection wavelength changes relative peak areas for chromophore-bearing impurities.
Integration thresholds determine which small peaks are counted at all.
Sample solvent mismatch can distort early-eluting peak shape.

Frequently asked questions

Why is 214 nm used for peptide detection?: The peptide bond itself absorbs strongly near 214 nm, so detection at that wavelength responds to the backbone rather than depending on aromatic side chains.
Can HPLC alone confirm that a vial contains the intended peptide?: No. Chromatography reports how the sample separates, not what the separated component is. Identity assignment requires a mass measurement or another orthogonal method.
What does an unexpected extra peak indicate?: It indicates a detected component other than the main peak. Interpretation requires the method context; possibilities include synthesis-related impurities, degradation products, or solvent and matrix peaks.
Is a single injection sufficient?: Analytical practice generally relies on replicate injections and system suitability checks so that reported values reflect a stable, reproducible measurement.

References

United States Pharmacopeia — General Chapter <621> Chromatography — U.S. Pharmacopeia
ICH Q2(R2) Validation of Analytical Procedures — International Council for Harmonisation

Research use only. The information in this library is educational and is not medical advice. Products are not intended to diagnose, treat, cure, or prevent disease and are not for human or veterinary consumption.